For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for Tesamorelin

Vial comparison

Tesamorelin prices

Compare Tesamorelin listings by strength, selection and supplier. Inspect the original source behind each price.

47suppliers represented
98source-linked listings
6strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 2 mg1 supplier · Pack counts: 1
  • 5 mg12 suppliers · Pack counts: 1
  • 10 mg41 suppliers · Pack counts: 1, 2, 3, 5, 6, 10
  • 12 mg1 supplier · Pack counts: 1
  • 20 mg16 suppliers · Pack counts: 1, 2, 3, 5, 10
  • 30 mg3 suppliers · Pack counts: 1

Reported quantities in this family: 1, 2, 3, 5, 6, 10. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
2 mg1 vial$50.00$25.001Compare
5 mg1 vial$25.29$5.0612Compare
10 mg1 vial$30.24$3.0237Compare
12 mg1 vial$32.99$2.751Compare
20 mg1 vial$47.00$2.3515Compare
30 mg1 vial$96.00$3.202Compare

Suppliers with Tesamorelin listings

47 profiles
View 41 more supplier profiles

Sources and comparison limits

8 listings from direct supplier captures and 90 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more vial listings

Browse all products

FROM PEPTIDES CALCULATOR

About Tesamorelin

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoyl group on its N-terminus that protects it from enzymatic breakdown. Developed by Theratechnologies under the code TH9507, it was approved by the FDA in 2010 as Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, and is sold today as Egrifta SV and Egrifta WR. It has also been studied for liver fat in people with HIV and fatty liver disease and for cognition in older adults, and is used off-label in body-composition and anti-aging practice.

Formula
C221 H366 N72 O67 S
Molar mass
5,136 g/mol
CAS number
218949-48-5
Amino acids
44

Research evidence described in the source

Not graded

Research on Tesamorelin

Tesamorelin: An Analogue of GHRH Tesamorelin is an analogue of growth hormone-releasing hormone (GHRH), and it shares similar effects with GHRH and other GHRH analogues like sermorelin, GRF (1-29), and CJC-1295.…

Not graded

Conclusion

Tesamorelin reduces inflammation, lowers cardiovascular risk, and supports healthy growth hormone levels, particularly in HIV patients. It also shows promise in treating peripheral nerve damage and cognitive impairment.

Limitations noted in the source

  • Individual claims and source links have not yet completed editorial verification.
  • Evidence level, applicable study model, formulation, route and population remain unassigned.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.